This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.
Protocol Amendment History
5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-15; most recent amendment 2025-01-21.
Status change: Active, Not Recruiting → Recruiting2025-01-21
Status change: Recruiting → Active, Not Recruiting2023-12-14